Safety and Efficacy of Avalglucosidase Alfa in Patients With Non-classic Pompe Disease Aged ≥ 5 Years

Clinical trial NCT07652814 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07652814
Sponsor: Iris Plug
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Glycogen Storage Disease Type II Late Onset Pompe Disease (Late-onset)Pompe Disease Late-Onset Pompe's Disease Juvenile Onset Pompe Disease

Start date: 2022-10-13
Primary completion: 2028-03-09
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.